| Darwin | Very Good Site <a href=" http://www.japansociety-ni.org.uk/buy-detrol-online/ ">adventure buy detrol online traditionally</a> The headline Sanofi was looking for today centers on a 23% drop in the number of patients suffering from low blood sugar--hypoglycemia--when compared to the Lantus arm. A slate of late-stage studies also demonstrated a similar drop in in HbA1c over 6 months, leaving the company with a solid claim for non-inferiority that will be needed to protect the critical $6.5 billion franchise carved out by Lantus, which loses patent protection in 2015. But in one of the Phase III studies involving insulin-naïve patients U300 failed the primary endpoint on lowering incidents of hypoglycemia. |
|